Journal
INTERNATIONAL IMMUNOLOGY
Volume 27, Issue 6, Pages 281-287Publisher
OXFORD UNIV PRESS
DOI: 10.1093/intimm/dxu144
Keywords
anaemia of chronic disease; hepcidin; IL-22; inflammation; iron
Categories
Funding
- National Health and Medical Research Council (NHMRC) of Australia [1031325, 1048000]
- NHMRC Senior Research Fellowship [1024672]
Ask authors/readers for more resources
The anaemia of chronic disease (ACD) results from inflammation-mediated up-regulation of the iron regulatory hormone hepcidin, with the consequent sequestration of iron limiting its availability for erythropoiesis. The inflammatory cytokine IL-6, a regulator of hepcidin, has been implicated in this process. Recent in vivo and in vitro studies indicate that IL-22 is also able to stimulate hepcidin expression. We aimed to determine if IL-22 had a role in causing the hypoferremia associated with the inflammatory response. Wild-type and II22-knockout mice were subjected to an acute inflammatory stimulus via administration of LPS and the response of hepcidin and iron homeostasis was analysed. In the absence of IL-22, there was a response of hepcidin, resulting in a reduction in serum iron levels. However, the hypoferremic response to LPS was slightly blunted in mice lacking IL-22, suggesting that, during LPS-mediated inflammation, IL-22 may play a minor role in mediating the hypoferremic response. These results may have implications for the treatment and management of the ACD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available